Drugs / Chlorphenamine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 4 | NCT06907355 Background | May → Nov 2025 | respiratory tract infectious disorder | Pontificia Universidad Catolica de Chile | Completed | No outcome recorded |
| — | NCT01209455 Comparator | Jan → Jul 2011 | poisoning | University of Edinburgh | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Chlorphenamine | “Codeine 10mg/5ml + Pseudoephedrine 7.5mg/5ml + Chlorphenamine 0.5mg/5ml: 10ml three times per day during 4 days” NCT06907355 ↗ |
| Action | Inhibit | “chlorphenamine (H1 antagonist)” NCT01209455 ↗ |
| Route | Other | “IA administration of 1 mcg/min would achieve a similar forearm concentration. Assuming NAC causes vasodilatation with an increase in forearm blood flow, the investigators...” NCT01209455 ↗ |